AstraZeneca signs COVID treatment deal with China’s Genertec Meheco
BEIJING (Reuters) – AstraZeneca has signed a cooperation agreement with China’s Genertec Meheco for COVID-19 antibody drug Evusheld, it said on Friday. Genertec Meheco, a unit of Shanghai-listed China Meheco Group Co, will be responsible for the import and distribution of Evusheld in mainland China once the drug is approved to enter the Chinese market …
AstraZeneca signs COVID treatment deal with China’s Genertec Meheco Read More »










